Regulation of degenerative spheroids after injury.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 09 2020
Historique:
received: 14 05 2020
accepted: 05 08 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 16 12 2020
Statut: epublish

Résumé

Neuronal injury leads to rapid, programmed disintegration of axons distal to the site of lesion. Much like other forms of axon degeneration (e.g. developmental pruning, toxic insult from neurodegenerative disorder), Wallerian degeneration associated with injury is preceded by spheroid formation along axons. The mechanisms by which injury leads to formation of spheroids and whether these spheroids have a functional role in degeneration remain elusive. Here, using neonatal mouse primary sympathetic neurons, we investigate the roles of players previously implicated in the progression of Wallerian degeneration in injury-induced spheroid formation. We find that intra-axonal calcium flux is accompanied by actin-Rho dependent growth of calcium rich axonal spheroids that eventually rupture, releasing material to the extracellular space prior to catastrophic axon degeneration. Importantly, after injury, Sarm1

Identifiants

pubmed: 32963272
doi: 10.1038/s41598-020-71906-x
pii: 10.1038/s41598-020-71906-x
pmc: PMC7508847
doi:

Substances chimiques

Armadillo Domain Proteins 0
Cytoskeletal Proteins 0
Nerve Tissue Proteins 0
Receptors, Tumor Necrosis Factor 0
SARM1 protein, mouse 0
Tnfrsf21 protein, mouse 0
Wld protein, mouse 0
Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15472

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS091617
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS091617
Pays : United States

Références

Waller, A. Experiments on the section of the glosso-pharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Edinb. Med. Surg. J. 76, 369–376 (1851).
pubmed: 30332247 pmcid: 5929074
Beirowski, B. et al. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci. 6, 6 (2005).
pubmed: 15686598 pmcid: 549193 doi: 10.1186/1471-2202-6-6
Wang, J. T., Medress, Z. A. & Barres, B. A. Axon degeneration: molecular mechanisms of a self-destruction pathway. J. Cell Biol. 196, 7–18 (2012).
pubmed: 22232700 pmcid: 3255986 doi: 10.1083/jcb.201108111
Vargas, M. E., Yamagishi, Y., Tessier-Lavigne, M. & Sagasti, A. Live Imaging of calcium dynamics during axon degeneration reveals two functionally distinct phases of calcium Influx. J. Neurosci. 35, 15026–15038 (2015).
pubmed: 26558774 pmcid: 4642236 doi: 10.1523/JNEUROSCI.2484-15.2015
Avery, M. A. et al. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca
pubmed: 22425157 pmcid: 4175988 doi: 10.1016/j.cub.2012.02.043
George, E. B., Glass, J. D. & Griffin, J. W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neurosci. 15, 6445–6452 (1995).
pubmed: 7472407 pmcid: 6577979 doi: 10.1523/JNEUROSCI.15-10-06445.1995
Adalbert, R. et al. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons. Neuroscience 225, 44–54 (2012).
pubmed: 22960623 doi: 10.1016/j.neuroscience.2012.08.056 pmcid: 22960623
Yang, J. et al. Regulation of axon degeneration after injury and in development by the endogenous calpain inhibitor calpastatin. Neuron 80, 1175–1189 (2013).
pubmed: 24210906 doi: 10.1016/j.neuron.2013.08.034 pmcid: 24210906
Ma, M. et al. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration. Neurobiol. Dis. 56, 34–46 (2013).
pubmed: 23542511 pmcid: 3721029 doi: 10.1016/j.nbd.2013.03.009
Yong, Y. et al. p75NTR and DR6 regulate distinct phases of axon degeneration demarcated by spheroid rupture. J. Neurosci. 39, 9503–9520 (2019).
pubmed: 31628183 pmcid: 6880466 doi: 10.1523/JNEUROSCI.1867-19.2019
Saxena, S. & Caroni, P. Mechanisms of axon degeneration: from development to disease. Prog. Neurobiol. 83, 174–191 (2007).
pubmed: 17822833 doi: 10.1016/j.pneurobio.2007.07.007 pmcid: 17822833
Llobet Rosell, A. & Neukomm, L. J. Axon death signalling in Wallerian degeneration among species and in disease. Open Biol. 9, 190118 (2019).
pubmed: 31455157 pmcid: 6731592 doi: 10.1098/rsob.190118
Coleman, M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6, 889–898 (2005).
pubmed: 16224497 doi: 10.1038/nrn1788 pmcid: 16224497
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H. & Gordon, S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1, 27–33 (1989).
pubmed: 12106171 doi: 10.1111/j.1460-9568.1989.tb00771.x pmcid: 12106171
Brown, M. C., Lunn, E. R. & Perry, V. H. Consequences of slow Wallerian degeneration for regenerating motor and sensory axons. J. Neurobiol. 23, 521–536 (1992).
pubmed: 1431835 doi: 10.1002/neu.480230507 pmcid: 1431835
Conforti, L. et al. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl. Acad. Sci. USA 97, 11377–11382 (2000).
pubmed: 11027338 doi: 10.1073/pnas.97.21.11377 pmcid: 11027338
Sasaki, Y., Araki, T. & Milbrandt, J. Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. J. Neurosci. 26, 8484–8491 (2006).
pubmed: 16914673 pmcid: 6674352 doi: 10.1523/JNEUROSCI.2320-06.2006
Gilley, J. & Coleman, M. P. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 8, e1000300 (2010).
pubmed: 20126265 pmcid: 2811159 doi: 10.1371/journal.pbio.1000300
Summers, D. W., Milbrandt, J. & DiAntonio, A. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors. Proc. Natl. Acad. Sci. USA 115, E8746–E8754 (2018).
pubmed: 30150401 doi: 10.1073/pnas.1806933115 pmcid: 30150401
Walker, L. J. et al. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2. elife 6, e22540 (2017).
pubmed: 28095293 pmcid: 5241118 doi: 10.7554/eLife.22540
Milde, S., Gilley, J. & Coleman, M. P. Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. PLoS Biol. 11, e1001539 (2013).
pubmed: 23610559 pmcid: 3627647 doi: 10.1371/journal.pbio.1001539
Osterloh, J. M. et al. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337, 481–484 (2012).
pubmed: 22678360 pmcid: 5225956 doi: 10.1126/science.1223899
Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A. & Milbrandt, J. SARM1 activation triggers axon degeneration locally via NAD
pubmed: 25908823 pmcid: 4513950 doi: 10.1126/science.1258366
Essuman, K. et al. The SARM1 toll/interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration. Neuron 93, 1334.e5-1343.e5 (2017).
doi: 10.1016/j.neuron.2017.02.022
Gamage, K. K. et al. Death receptor 6 promotes wallerian degeneration in peripheral axons. Curr. Biol. 27, 890–896 (2017).
pubmed: 28285993 pmcid: 5360522 doi: 10.1016/j.cub.2017.01.062
Zhai, Q. et al. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39, 217–225 (2003).
pubmed: 12873380 doi: 10.1016/S0896-6273(03)00429-X pmcid: 12873380
Larhammar, M. et al. Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult. elife 6, e20725 (2017).
pubmed: 28440222 pmcid: 5404924 doi: 10.7554/eLife.20725
Yang, J. et al. Pathological axonal death through a MAPK cascade that triggers a local energy deficit. Cell 160, 161–176 (2015).
pubmed: 25594179 pmcid: 4306654 doi: 10.1016/j.cell.2014.11.053
Babetto, E., Beirowski, B., Russler, E. V., Milbrandt, J. & DiAntonio, A. The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction. Cell Rep. 3, 1422–1429 (2013).
pubmed: 23665224 pmcid: 3671584 doi: 10.1016/j.celrep.2013.04.013
Murata, H. et al. c-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD+ cleavage activity to inhibit mitochondrial respiration. J. Biol. Chem. 293, 18933–18943 (2018).
pubmed: 30333228 pmcid: 6295714 doi: 10.1074/jbc.RA118.004578
Neukomm, L. J. et al. Axon death pathways converge on axundead to promote functional and structural axon disassembly. Neuron 95, 78.e5-91.e5 (2017).
doi: 10.1016/j.neuron.2017.06.031
Ridley, A. J. Rho family proteins: coordinating cell responses. Trends Cell Biol. 11, 471–477 (2001).
pubmed: 11719051 doi: 10.1016/S0962-8924(01)02153-5 pmcid: 11719051
Luo, L. & O’Leary, D. D. M. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28, 127–156 (2005).
pubmed: 16022592 doi: 10.1146/annurev.neuro.28.061604.135632 pmcid: 16022592
Koch, J. C. et al. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis. 5, e1225 (2014).
pubmed: 24832597 pmcid: 4047920 doi: 10.1038/cddis.2014.191
Stankiewicz, T. R. & Linseman, D. A. Rho family GTPases: key players in neuronal development, neuronal survival, and neurodegeneration. Front. Cell. Neurosci. 8, 314 (2014).
pubmed: 25339865 pmcid: 4187614 doi: 10.3389/fncel.2014.00314
Dubreuil, C. I., Winton, M. J. & McKerracher, L. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162, 233–243 (2003).
pubmed: 12860969 pmcid: 2172802 doi: 10.1083/jcb.200301080
Yamagishi, S. et al. Wallerian degeneration involves Rho/Rho-kinase signaling. J. Biol. Chem. 280, 20384–20388 (2005).
pubmed: 15799964 doi: 10.1074/jbc.M501945200 pmcid: 15799964
Mi, W. et al. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128, 405–416 (2005).
pubmed: 15644421 doi: 10.1093/brain/awh368 pmcid: 15644421
Sasaki, S., Warita, H., Abe, K. & Iwata, M. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 110, 48–56 (2005).
pubmed: 15920660 doi: 10.1007/s00401-005-1021-9 pmcid: 15920660
Beirowski, B., Nógrádi, A., Babetto, E., Garcia-Alias, G. & Coleman, M. P. Mechanisms of axonal spheroid formation in central nervous system Wallerian degeneration. J. Neuropathol. Exp. Neurol. 69, 455–472 (2010).
pubmed: 20418780 doi: 10.1097/NEN.0b013e3181da84db pmcid: 20418780
Conforti, L., Gilley, J. & Coleman, M. P. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat. Rev. Neurosci. 15, 394–409 (2014).
pubmed: 24840802 doi: 10.1038/nrn3680 pmcid: 24840802
Barsukova, A. G., Forte, M. & Bourdette, D. Focal increases of axoplasmic Ca
pubmed: 22933787 pmcid: 3484163 doi: 10.1523/JNEUROSCI.0408-12.2012
Hall, A. Rho GTPases and the actin cytoskeleton. Science 279, 509–514 (1998).
pubmed: 9438836 doi: 10.1126/science.279.5350.509 pmcid: 9438836
Witte, M. E. et al. Calcium influx through plasma-membrane nanoruptures drives axon degeneration in a model of multiple sclerosis. Neuron 101, 615.e5-624.e5 (2019).
doi: 10.1016/j.neuron.2018.12.023
Eddleman, C. S., Ballinger, M. L., Smyers, M. E., Fishman, H. M. & Bittner, G. D. Endocytotic formation of vesicles and other membranous structures induced by Ca
pubmed: 9592084 pmcid: 6792792 doi: 10.1523/JNEUROSCI.18-11-04029.1998
Di Stefano, M. et al. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ. 22, 731–742 (2015).
pubmed: 25323584 doi: 10.1038/cdd.2014.164 pmcid: 25323584
Wang, J. et al. A local mechanism mediates NAD-dependent protection of axon degeneration. J. Cell Biol. 170, 349–355 (2005).
pubmed: 16043516 pmcid: 2171458 doi: 10.1083/jcb.200504028
Sasaki, Y., Nakagawa, T., Mao, X., DiAntonio, A. & Milbrandt, J. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion. elife 5, e19749 (2016).
pubmed: 27735788 pmcid: 5063586 doi: 10.7554/eLife.19749
Wang, G. et al. Structural plasticity of actin-spectrin membrane skeleton and functional role of actin and spectrin in axon degeneration. elife 8, e38730 (2019).
pubmed: 31042147 pmcid: 6494423 doi: 10.7554/eLife.38730
Zhong, G. et al. Developmental mechanism of the periodic membrane skeleton in axons. elife 3, e04581 (2014).
pmcid: 4337613 doi: 10.7554/eLife.04581
Lorenzo, D. N. et al. βII-spectrin promotes mouse brain connectivity through stabilizing axonal plasma membranes and enabling axonal organelle transport. Proc. Natl. Acad. Sci. USA 116, 15686–15695 (2019).
pubmed: 31209033 doi: 10.1073/pnas.1820649116 pmcid: 31209033
Zhou, R., Han, B., Xia, C. & Zhuang, X. Membrane-associated periodic skeleton is a signaling platform for RTK transactivation in neurons. Science 365, 929–934 (2019).
pubmed: 31467223 pmcid: 7063502 doi: 10.1126/science.aaw5937
Gerdts, J., Summers, D. W., Milbrandt, J. & DiAntonio, A. Axon self-destruction: new links among SARM1, MAPKs, and NAD+ metabolism. Neuron 89, 449–460 (2016).
pubmed: 26844829 pmcid: 4742785 doi: 10.1016/j.neuron.2015.12.023
Coleman, M. P. & Höke, A. Programmed axon degeneration: from mouse to mechanism to medicine. Nat. Rev. Neurosci. 21, 183–196 (2020).
pubmed: 32152523 doi: 10.1038/s41583-020-0269-3 pmcid: 32152523
Sasaki, Y. et al. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Exp. Neurol. 329, 113252 (2020).
pubmed: 32087251 doi: 10.1016/j.expneurol.2020.113252 pmcid: 32087251
Guse, A. H. Calcium mobilizing second messengers derived from NAD. Biochim. Biophys. Acta 1854, 1132–1137 (2015).
pubmed: 25534250 doi: 10.1016/j.bbapap.2014.12.015 pmcid: 25534250
Villegas, R. et al. Calcium release from intra-axonal endoplasmic reticulum leads to axon degeneration through mitochondrial dysfunction. J. Neurosci. 34, 7179–7189 (2014).
pubmed: 24849352 pmcid: 4028495 doi: 10.1523/JNEUROSCI.4784-13.2014
Orem, B. C., Pelisch, N., Williams, J., Nally, J. M. & Stirling, D. P. Intracellular calcium release through IP3R or RyR contributes to secondary axonal degeneration. Neurobiol. Dis. 106, 235–243 (2017).
pubmed: 28709993 doi: 10.1016/j.nbd.2017.07.011 pmcid: 28709993
Nikiforov, A., Kulikova, V. & Ziegler, M. The human NAD metabolome: functions, metabolism and compartmentalization. Crit. Rev. Biochem. Mol. Biol. 50, 284–297 (2015).
pubmed: 25837229 pmcid: 4673589 doi: 10.3109/10409238.2015.1028612
Mitchell, L., Hobbs, G. A., Aghajanian, A. & Campbell, S. L. Redox regulation of Ras and Rho GTPases: mechanism and function. Antioxid. Redox Signal. 18, 250–258 (2013).
pubmed: 22657737 pmcid: 3518547 doi: 10.1089/ars.2012.4687
Heo, J. & Campbell, S. L. Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases. J. Biol. Chem. 280, 31003–31010 (2005).
pubmed: 15994296 doi: 10.1074/jbc.M504768200 pmcid: 15994296
Zhao, Z. Y. et al. A cell-permeant mimetic of NMN activates SARM1 to produce cyclic ADP-ribose and induce non-apoptotic cell death. iScience 15, 452–466 (2019).
pubmed: 31128467 pmcid: 6531917 doi: 10.1016/j.isci.2019.05.001
Ko, K. W., Milbrandt, J. & DiAntonio, A. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration. J. Cell Biol. 219, e201912047 (2020).
pubmed: 32609299 doi: 10.1083/jcb.201912047 pmcid: 32609299
Wang, Q. et al. Sarm1/Myd88-5 regulates neuronal intrinsic immune response to traumatic axonal injuries. Cell Rep. 23, 716–724 (2018).
pubmed: 29669278 doi: 10.1016/j.celrep.2018.03.071 pmcid: 29669278
Galindo, R. et al. NMNAT3 is protective against the effects of neonatal cerebral hypoxia-ischemia. Ann. Clin. Transl. Neurol. 4, 722–738 (2017).
pubmed: 29046881 pmcid: 5634348 doi: 10.1002/acn3.450
Adalbert, R., Gilley, J. & Coleman, M. P. Aβ, tau and ApoE4 in Alzheimer’s disease: the axonal connection. Trends Mol. Med. 13, 135–142 (2007).
pubmed: 17344096 doi: 10.1016/j.molmed.2007.02.004 pmcid: 17344096
Kanaan, N. M. et al. Axonal degeneration in Alzheimer’s disease: when signaling abnormalities meet the axonal transport system. Exp. Neurol. 246, 44–53 (2013).
pubmed: 22721767 doi: 10.1016/j.expneurol.2012.06.003 pmcid: 22721767
Howell, G. R. et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 179, 1523–1537 (2007).
pubmed: 18158332 pmcid: 2373494 doi: 10.1083/jcb.200706181
Tian, W., Czopka, T. & López-Schier, H. Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration. Commun. Biol. 3, 49 (2020).
pubmed: 32001778 pmcid: 6992705 doi: 10.1038/s42003-020-0776-9
Tian, N., Hanson, K. A., Canty, A. J., Vickers, J. C. & King, A. E. Microtubule-dependent processes precede pathological calcium influx in excitotoxin-induced axon degeneration. J. Neurochem. 152, 542–555 (2020).
pubmed: 31705657 doi: 10.1111/jnc.14909 pmcid: 31705657
Rosenberg, A. F., Wolman, M. A., Franzini-Armstrong, C. & Granato, M. In vivo nerve-macrophage interactions following peripheral nerve injury. J. Neurosci. 32, 3898–3909 (2012).
pubmed: 22423110 pmcid: 3324096 doi: 10.1523/JNEUROSCI.5225-11.2012
Deppmann, C. D. et al. A model for neuronal competition during development. Science 320, 369–373 (2008).
pubmed: 18323418 pmcid: 3612357 doi: 10.1126/science.1152677
Loreto, A., Di Stefano, M., Gering, M. & Conforti, L. Wallerian degeneration is executed by an NMN-SARM1-dependent late Ca(2+) influx but only modestly influenced by mitochondria. Cell Rep. 13, 2539–2552 (2015).
pubmed: 26686637 doi: 10.1016/j.celrep.2015.11.032 pmcid: 26686637
Singh, K. K. et al. Developmental axon pruning mediated by BDNF-p75NTR-dependent axon degeneration. Nat. Neurosci. 11, 649–658 (2008).
pubmed: 18382462 doi: 10.1038/nn.2114 pmcid: 18382462
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
doi: 10.1038/nmeth.2019

Auteurs

Yu Yong (Y)

Department of Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA.

Kanchana Gamage (K)

Amgen, Massachusetts and Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.

Courtny Cushman (C)

Department of Neuroscience and Biomedical Engineering, University of Virginia, Charlottesville, VA, 22904-4328, USA.

Anthony Spano (A)

Department of Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA.

Christopher Deppmann (C)

Department of Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA. deppmann@virginia.edu.
Department of Neuroscience and Biomedical Engineering, University of Virginia, Charlottesville, VA, 22904-4328, USA. deppmann@virginia.edu.
Department of Cell Biology, University of Virginia, Charlottesville, VA, 22904-4328, USA. deppmann@virginia.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH